The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

Emma Young, MS, and Avner Schlessinger, PhD, conduct structural analysis of a novel drug target at the AI Small Molecule Drug ...